View of Roxithromycin as Anti-Inflammatory Drug Improves Clinical Outcomes in Adult Patients with Bronchiectasis: A Double- Blinded Randomized, Placebo-Controlled Pilot Clinical Trial

Official Journal Health Science of Prince of Songkla University

Return to Article Details Roxithromycin as Anti-Inflammatory Drug Improves Clinical Outcomes in Adult Patients with Bronchiectasis: A Double- Blinded Randomized, Placebo-Controlled Pilot Clinical Trial Download Download PDF

นโยบายการคุ้มครองข้อมูลส่วนบุคคล Privacy policy